Biomarkers · 2021 · 11 citations · 13 references
MedicineCardiologyObstetricsHigh-risk PregnancyMaternal-fetal MedicinePrenatal DiagnosisCongenital Heart DiseaseCongenital Structural Heart DiseaseFetal AnomaliesFetal CardiologyPrenatal Risk AssessmentCongenital Heart Defects EpidemiologyControl Group DesignFirst Trimester UltrasonographyIsolated Congenital DisordersMatched Control GroupNuchal Translucency ScreeningProspective Cohort DataSerum Biomarkers
Background This study aims to assess the association between first-trimester biomarkers in foetuses with a non-chromosomal congenital heart defect (CHD) and compares it to the matched healthy foetuses.Method Nuchal Translucency (NT), Pregnancy-Associated Plasma Protein-A (PAPP-A) and free beta-human Chorionic Gonadotropin (β-hCG) were evaluated in 56 isolated foetal heart defects and 224 controls. The CHDs were further divided into Critical CHD (C-CHD) and Non-critical CHD (N-CHD) groups.Results The multiple of the median (MoM) values for PAPP-A were significantly lower (0.87 MoM vs. 0.92 MoM; p = 0.008) in the total CHD group than in controls. The median of foetal NT values was significantly higher in the total CHDs than in controls (1.16 MoM vs. 1.03 MoM; p < 0.001), especially for C-CHDs (1.28 MoM; P < 0.001). There were no significant differences in terms of PAPP-A (p = 0.779) and foetal NT values (p = 0.760) between the N-CHDs and control groups. There were no significant differences within the groups based on free β-hCG, except for a lower β-hCG in C-CHD group than in the control group (0.95 MoM vs. 1.11 MoM; p = 0.022).Conclusion Lower PAPP-A levels and increased NT thickness were associated with an increased risk of CHDs, especially the critical type of CHDs.Clinical significanceMaternal serum PAPP-A, measured in the first trimester, is significantly lower in CHD.Foetal NT is significantly thicker in foetuses with CHD, especially those with critical CHD.Maternal serum β-hCG was only decreased among critical CHD group.
13
Strategies for Implementing Screening for Critical Congenital Heart Disease
Alex R. Kemper, William T. Mahle, Gerard R. Martin et al. · PEDIATRICS · 2011 · 420 citations
Medicine, Cardiology, Pediatrics +17
James P. Youngblood · Obstetrics and Gynecology · 1999 · 315 citations
Medicine, Gynecology, Obstetrics +5
Maternal age and malformations in singleton births
Larry H. Hollier · Obstetrics and Gynecology · 2000 · 243 citations
Maternal Obesity and Infant Heart Defects
Marie I. Cedergren, Bëngt Källén · Obesity Research · 2003 · 186 citations